论文信息 - A Novel HER2-targeted Antibody–drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-equivalent Exposure Levels - 字舞流文

A Novel HER2-targeted Antibody–drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-equivalent Exposure Levels

M. Pegram | P. Drake | Fangjiu Zhang | David Rabuka | S. Chuprakov | Robyn M. Barfield | Y. Kim | M. Bauzon | A. Ogunkoya | Dominick Yeo | Colin Hickle